Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001576280-21-000013
Filing Date
2021-02-05
Accepted
2021-02-05 17:03:20
Documents
1
Period of Report
2020-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161256258436886.html 4  
1 FORM 4 wf-form4_161256258436886.xml 4 36066
  Complete submission text file 0001576280-21-000013.txt   37378
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Issuer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 18 ISABELLA AVENUE ATHERTON CA 94027
Business Address
Talasaz AmirAli (Reporting) CIK: 0001753159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38683 | Film No.: 21596990